Affordable Access

deepdyve-link deepdyve-link
Publisher Website

miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer.

Authors
Type
Published Article
Journal
Frontiers in Oncology
2234-943X
Publisher
Frontiers Media SA
Publication Date
Volume
4
Pages
207–207
Identifiers
DOI: 10.3389/fonc.2014.00207
PMID: 25177545
Source
Medline
Keywords
  • Her2
  • Biomarker
  • Breast Cancer
  • Mir-21
  • Prediction
  • Response
  • Trastuzumab

Abstract

Statistics

Seen <100 times